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Abstract

Keywords

Objective. This study explored Early Maladjustment Schemas (EMSs) among
individuals with and without type 2 diabetes mellitus and examined potential moderating
roles for gender, level of education, and occupation.
Methods. The sample included 371 adult participants (120 patients with diabetes and
251 individuals without diabetes), from Shiraz City, Fars province; Iran. The Young
Schema Questionnaire-Short Form (YSQ-SF) was used to assess early maladjustment
schemas.
Results. Findings showed that patients with type 2 diabetes had significantly higher
scores than controls on a number of EMSs, including abandonment, failure,
vulnerability, enmeshment, self-sacrifice, entitlement, and insufficient self-control
schemas as well as the over-vigilance and inhibition schematic domains. However,
results did not support roles for gender, the level of education, and occupation on any of
EMSs and schematic domains.
Conclusions. Medical and health professionals may find these results helpful for
assessment, treatment, and prevention goals in patients with type 2 diabetes.


Type 2 Diabetes Mellitus; Normal individuals; Early Maladjustment Schemas;
Schematic Domains.

Highlights

 Patients with type 2 diabetes mellitus have significantly higher scores in abandonment,
failure, vulnerability, enmeshment, self-sacrifice, entitlement and insufficient self control

schemas.
 Patients with type 2 diabetes mellitus have significantly higher scores in over-vigilance
and inhibition schematic domains.
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Introduction
Diabetes mellitus is a major health problem,
particularly in the Middle East (1). The prevalence of
diabetes has increased rapidly in Iran since the first
national comprehensive survey in 1999 to the present (2).
For example, trend analyses show a 35% increase in the
prevalence rate of diabetes among Iranian adults from
2005 to 2011 (3). Moreover among all cases of diabetes,
the proportion of type 2 diabetes mellitus (T2DM) was
85.5% in the country in 2015–2016 (4). Studies have
demonstrated a higher prevalence in females (12.86%)
than males (9.90%). From a psychopathological
perspective, research has shown that psychological
distress, agitation, and mental preoccupation with disease
are common in patients with diabetes mellitus (5). Thus,
diabetes-related distress is an indicator of health-related
quality of life in patients with this disease, as it relates to
how patients may handle their negative emotions toward
the diagnosis and complications of diabetes, how to
achieve good self-management, and how to access
appropriate social support for an effective outcome (6, 7).
Chronic distress can predispose diabetic patients for
the development of various psychopathologcial and
psychological disorders, with many studies demonstrating
that anxiety disorders and depression are the most
frequent psychiatric comorbid conditions in patients with
type 2 diabetes (8-11). In addition, investigations have
affirmed that cognitive dysfunction as a form of
psychopathology is frequent among patients with type 2
diabetes, and this dysfunction can influence self-care and
general quality of life (12-14). Munshi (2017) showed
that cognitive dysfunctions in patients with type 2
diabetes can vary on a spectrum from a mild impairment
(i.e., cognitive dysfunction without difficulty performing
daily activities) to severe dysfunction (i.e., dementia).
In general, “schema” is an indicator of both functional
and dysfunctional cognitive functioning. Schemas are
considered the basis for perception, classification,
viewing, differentiating, and encoding of different stimuli
encountered by individuals during the course of their
lifetime (15). In the fields of cognitive psychology,
cognitive development, self-psychology, and attachment
theory, the concept of schema is used to understand and
explain the developmental nature of psychopathology
among patients with mental disorders or physical diseases
(16). Segal (1988) suggested that each schema shows
some ingredients of past reactions and experiences, which
shape a fairly cohesive entity of knowledge and directs
the consecutive perception and appraisals in everyday life
(17). Young (1990) refers to schema as "templates for the

processing of later experience". The development of early
maladaptive schemas (EMSs) may lead to dysfunctional
and self-preserving mechanisms throughout one’s lifetime, which in turn lead an individual to perform and
behave in maladaptive ways involving distorting reality,
stress and pessimism.
Research has further demonstrated that dysfunctional
cognitive schemas have influential roles on the
development of psychosomatic disorders (18, 19). For
instance, Dattilio (2010) conceptualized that generalized/
superordinate level of cognitive schemas are resistant to
change and that they have a powerful influence over
thoughts, affects, behaviors, and even physical and
physiologic processes in patients with physical diseases.
Since both the immune system and central nervous system
have the capacity to learn and form memory, Dattilio
(2010) suggested that a form of storage for cognitive
schema is located not only in the brain but also in cells
that are distributed throughout the entire body (15).
According to the mind theory as the function of brain-cell
connection (15), it appears that cognitive schemas can
influence the whole-body performance in patients with
psychosomatic and chronic diseases. In line with the
aforesaid conceptualizations, several studies have
highlighted dysfunctional schema in patient with physical
diseases. Ameri and colleagues (2014) indicated a
significant difference between the mean scores of normal
individuals and asthmatic patients on all major domains of
EMSs, excepting other-directedness (20). Gojani and
colleagues (2017) showed that schema-based therapy can
reduce defeated schema, dependence vs. incompetence
schema, devotion schema, merit schema, stubbornly
criteria schema, and restraint/inadequate self-discipline
schema in patients with psoriasis (21).
However, there is still a lack of evidence about
maladaptive schemas in patients with type 2 diabetes.
Therefore, this study examined the Early Maladjustment
Schemas (EMSs) among individuals with and without
type 2 diabetes mellitus and investigated potential roles
for gender, the level of education, and occupation
variables.

The study design
Based on an integrative approach for behavioral and
psychosocial interventions in diabetes (22), motivators,
inhibitors/facilitators, intentions, and triggers are
considered as four factors which influences the outcome
of therapeutic interventions in patients. Motivators consist
of needs and outcome expectances, and predispose
patients to action and adherence to the treatment process.
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Inhibitors/facilitators represent either barriers or resources
for accomplishment of the treatment process. Intentions
are the external or inner cause for behavior change toward
the therapy goals. Triggers are the factors that change a
personal readiness into an action state (22). The present
study assumes that these four factors function in the
maladaptive schemas in disease-stress conceptualizations
and are important to an integrative approach for
biopsychological interventions in diabetes (5-7, 15-19,
22). This study further suggests that patients with diabetes
commonly have a multifaceted set of repetitive thoughts
and feelings about disease; worries about access to care;
concerns about nutrition and diet, physical action, drugs
and medications; psychological insulin confrontation; and
not receiving adequate support from family members and
others. Thus, the psychological distress response to
diabetes may become a significant contributor to
undesirable disease course, prognosis, and outcome, due
to its relationship to both reduced metabolic control and
impairment of the quality of life. Therefore, a careful
assessment of cognitive schematic dysfunctions in
patients with type 2 diabetes is essential for addressing
psychological distress, and may assist in increasing
treatment efficacy (23). Finally, this study suggests that
negative experiences and psychological distress due to
type 2 diabetes as a chronic disease can provoke some
EMSs, which could influence treatment management in
these patients. The present study hypothesizes that
individuals with and without type 2 diabetes will differ in
EMSs, with possible moderating effects from gender, the
level of education, and job variables.

Materials and Methods
Participants
The study sample consisted of 371 adult participants
(females with diabetes =96, males with diabetes =24,
females without diabetes=103, and males without
diabetes=148), from Shiraz City, Fars province, Iran.
Mean ages and standard deviation for individuals with
and without diabetes were 51.4 (SD=6.05) and 48.4
(SD=5.14) respectively. The level of education ranged
from less than diploma (N=100), to diploma (N=140),
skill degree (N=43), bachelor degree (N=73), and master
or doctorate (N=15). All participants were Muslim.
Participants were enlisted using a non-random purposeful
sampling strategy among over 30 year-old adults from
outpatient clinics in Shiraz City. Inclusion criteria for
patients with type 2 diabetes were: 1- over 30 years-old,
2- on diabetes care for more than six months, 3- meeting
all clinical criteria for type 2 diabetes, 4- free of clinical
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psychological or psychiatric co-morbidities that might
influence cognitive function, and 5- proficiency in the
Persian language. Inclusion criteria for individuals in the
control group were: 1- over 30 years-old, 2- free of
serious health complications during the past year, 3having no history of diabetes among his/her close
relatives, 4- having no PPG, 5- free of cardiovascular
disease, hypertension, or other chronic diseases, 6- having
a BMI lower than 25, 7- being a non-smoker and free of
drug abuse, 8- having no clinical psychological or
psychiatric co-morbidities that might affect cognitive
function, and 9- proficiency in the Persian language. Each
participant was addressed individually and completed the
study’s informed approval prior to contribution.
Materials
The Young Schema Questionnaire-Short Form (YSQSF; Young, 1998) was used to assess EMSs. The YSQ–
SF is a 75-item self-rating questionnaire which measures
the early maladjustment schemas. In this survey,
participants respond to items on a Likert-type scale from
1 (completely untrue of me) to 6 (describes me perfectly).
The YSQ–SF contains 15 subscales: Emotional
Deprivation (e.g., In general, people have not been there
to give me warmth, holding, and affection), Abandonment
(e.g., I worry that people I feel close to will leave me or
abandon me), Mistrust/Abuse (e.g., I feel that people will
take advantage of me), Social Isolation (e.g., I don't
belong; I'm a loner), Defectiveness (e.g.,. I feel that I'm
not lovable), Failure (e.g., I'm not as talented as most
people are at their work), Vulnerability (e.g., I worry
about being attacked), Dependence (e.g., I lack common
sense), Subjugation (e.g., In relationships, I let the other
person have the upper hand), Enmeshment (e.g., I often
feel that I do not have a separate identity from my
parent(s) or partner), Emotional Inhibition (e.g., I find it
hard to be warm and spontaneous), Self-Sacrifice (e.g., I
am a good person because I think of others more than of
myself), Entitlement (e.g., I hate to be constrained or kept
from doing what I want), Unrelenting Standards (e.g., I
must meet all my responsibilities), and Insufficient Self
Control (e.g., I have rarely been able to stick to my
resolutions) (24).
These 15 subscales fall into five domains including:
(a) Disconnection and Rejection, (b) Impaired Autonomy
and Performance, (c) Impaired Limits, (d) OtherDirectedness, and (e) Entitlement and Insufficient SelfControl. The first domain represents lack of sufficient
love and attention, supervision, and direction for the
individual by his/her family during childhood. This
domain assesses deterioration of the individual’s self-
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confidence and self-esteem by his/her parents in
childhood. The second domain represents leniency,
including a lack of regulations and boundaries in
childhood. The third domain represents pathological or
non-ordinary tendencies between children and families in
childhood. The fourth domain is an indication of low
power and poor self-control schemas. The fifth domain
represents the role of non-sympathetic and insensitive
parents who naturally valued self-control and self-denial
in their children (18).
The validity and reliability of the YSQ-SF have been
affirmed in clinical and non-clinical studies (24-26).
Research with the Persian language version of the YSQSF has demonstrated its validity and reliability in Iran
(27). Reliability analysis of the YSQ-SF using Cronbach’s
alpha indicates internal consistency of the domains,
Disconnection and Rejection (DR), Impaired Autonomy
and Performance (IAP), Impaired Limits (IL), OtherDirectedness (OD), and Over-Vigilance and Inhibition
(OVI) domains, found to be .90, .88, .92, .90, .94 and .90
respectively.

Results
To evaluate differences in EMSs across diabetic and
non-diabetic groups, a multivariate analysis of covariance
(MANCOVA) was performed, with group status, gender,
the level of education, and job type entered as fixed
independent variables and maladjustment schemas (i.e. 15
schemas and 5 schematic domains) as dependent
variables. This analysis showed differences based on
group status, Wilks’k = .712; F(15, 352) = 9.47; p <.0001)
regarding
abandonment,
failure,
vulnerability,
enmeshment, self-sacrifice, entitlement and insufficient
self control schemas; and over-vigilance and inhibition
schematic domains. Tests of between-subjects effects
using LSD posthoc analysis showed that patients with
type 2 diabetes had significantly higher scores in the
aforementioned 7 maladjustment schemas as well as the
over-vigilance and inhibition schematic domains than
non-diabetic controls (Table 1). However, this analysis
did not support moderating roles for gender, Wilks’k =
.975; F(15, 352) = .601; p <.87; the level of education,
Wilks’k = .968; F(15, 352) = .986; p <.889; and
occupation, Wilks’k = .964; F(15, 352) = .887; p <.57.

Discussions
Significant group differences for a number of EMSs
were found, specifically regarding abandonment, failure,
vulnerability, enmeshment, self-sacrifice, entitlement,
insufficient self control schemas, and over-vigilance and

inhibition schematic domain were found in this sample.
But no differences between clinical and control groups
were found on the other subscales: emotional deprivation,
mistrust/abuse,
social
isolation,
defectiveness,
dependence,
subjugation,
emotional
inhibition,
unrelenting standards, disconnection and rejection,
impaired autonomy and performance, impaired limits,
emotional inhibition and unrelenting standards schematic
domains in this sample. In general, these results are
consistent with predictions of a number of developmental
psychopathology (15-19, 28-31), as well as with the
assumptions of the disease-stress model and the
integrative approach for behavioral and psychosocial
interventions in diabetes (5-7, 15-19, 22) which suggest
schema differences associated with mental or physical
disease states.
These results are also consistent with previous
research which has supported the roles of maladaptive
schemas, cognitive dysfunctions, and a role for schema
therapy regarding the occurrence of or treatment for
chronic diseases. For example, Gojani and colleagues
reported that schema-based therapy can significantly
reduce EMSs in patients with psoriasis (21). Farrell and
colleagues showed a positive relationship between
cognitive distortions and perception of stress in children
and adolescents who were diagnosed with Type I diabetes
(32). Smith and colleagues demonstrated a positive
correlation between cognitive dysfunctions and disability
scores in patient with chronic low back pain and further
that pain-related and general cognitive dysfunctions
significantly correlated with depressed mood in patients
with rheumatoid arthritis (33-35). Bums and colleagues
recognized the influence of cognitive dysfunctions on the
treatment of chronic pain (34). Finally, Santos Ribas and
colleagues reported a significant positive association
between migraines and hypervigilance and inhibition,
unrelenting standards, and self-punishment maladaptive
schemas (36). In line with previous research supporting
roles for psychological distress, cognitive dysfunction,
and maladaptive schemas on development and treatment
of diabetes and other psychosomatic diseases (6-12, 14,
20-23), the present findings verify the influence of some
EMS’s in patients with type 2 diabetes. The study further
suggests that a similar predisposition to engage in
maladaptive cognitive schemas may influence healthrelated behaviors in patients with type 2 diabetes.
Therefore, these findings highlight how psychological
vulnerability and poor self-management of negative
emotions are associated with EMSs which may
predispose an individual for the progression or
maintenance of type 2 diabetes in his/her later life. Thus,
EMSs may play an important role in the establishment
and maintenance of psychological distress in patients with
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Type II diabetes. The underlying mechanism of EMSs is
assumed to occur at an autonomous level, developed as a
result of mental processing of childhood experiences, with
individuals later engaging in distorted thought processes
testing while attempting to establish a coherent image of

the chronic health threat. Patients' mental representations
of disease are therefore based on distinct maladaptive
schemas which in turn may affect the way they cope with
the disease, as seen in the over-vigilance and inhibition
schematic domains of patients with type 2 diabetes.

Table 1. Early Maladjustment Schemas in Individuals with and without Type 2 Diabetes Mellitus
Groups
Early Maladjustment Schemas

Type 2 Diabetes

Control Group

F

p

M

SD

M

SD

M

SD

Emotional deprivation

9.55

7.04

7.88

5.60

8.42

6.15

1.64

.20

Abandonment

13.49

7.18

9.78

6.79

10.98

7.12

11.72

.001

Mistrust/Abuse

6.83

4.07

6.35

3.82

6.67

3.91

1.75

.18

Social isolation

6.90

3.83

6.45

4.27

6.76

4.13

1.49

.22

Defectiveness

6.74

2.65

5.27

3.24

6.10

3.07

3.10

.07

Failure

10.72

5.68

7.84

5.07

8.77

5.43

10.11

.002

Dependence

6.90

4.36

6.65

4.09

6.82

4.18

1.80

.18

Vulnerability

10.95

5.55

7.58

5.05

8.67

5.44

20.56

.0001

Enmeshment

6.85

3.76

5.70

3.67

6.42

3.71

6.70

.01

Subjugation

6.69

4.55

6.58

3.99

6.78

4.18

1.68

.19

Self-sacrifice

12.25

7.42

10.06

7.39

10.77

7.46

3.48

.05

Emotional inhibition

7.78

4.79

7.43

5.39

7.67

5.20

1.01

.31

Unrelenting standards

16.94

3.22

15.16

3.75

16.09

3.59

.56

.45

Entitlement

12.26

3.99

11.00

4.46

11.85

4.35

9.85

.002

Insufficient self control

8.73

4.55

8.23

5.81

8.51

5.44

3.78

.05

Disconnection and Rejection
(I)

41.59

20.03

37.68

19.05

38.94

19.43

.65

.41

Impaired Autonomy and
Performance (II)

34.18

14.70

29.04

15.27

30.70

15.26

2.83

.09

Impaired Limits (III)

18.83

10.67

16.95

10.26

17.56

10.42

.65

.41

Emotional Inhibition and
Unrelenting Standards (IV)

23.95

6.94

23.37

7.83

23.76

7.55

1.10

.29

Over-Vigilance and
Inhibition (V)

21.06

7.85

19.00

9.66

20.37

9.14

7.03

.008

Conclusions
This study builds upon current thinking within
medical psychology by demonstrating higher levels of
some EMSs in patients with type 2 diabetes mellitus; at
the same time, no differences occurred due to gender, the
level of education, or occupation of the patients. Medical
and health professionals may utilize these findings to
assist in developing an integrated biopsychosocial
approach for the assessment, treatment, and prevention
goals in patients with type 2 diabetes. Likewise, these
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results may be valuable for instructional and educational
purposes by recognizing possible roles of maladjustment
schemas in the rehabilitation of patients with diabetes.
The study is limited by the use of a single self-rating
inventory in individuals with and without type 2 diabetes.
Future investigation may benefit from both quantitative
and qualitative procedures to explore how early
psychological experiences and dysfunctional emotionsregulation may influence the nature and severity of EMSs
in patients with type 2 diabetes.
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